Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3179.00    95.00 (3.08%)
Bid:
3186.00
Ask:
3188.00
Spread: 2.00 (0.063%)
Market Cap: £4.43b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

First Quarter Trading Statement

28 Apr 2011 07:00

RNS Number : 5748F
Croda International PLC
28 April 2011
 



28 April 2011

 

 

Croda International Plc

First quarter trading statement

 

Martin Flower, Chairman of Croda International Plc, is due to provide the following update on first quarter trading for the period ended 31 March 2011 at today's Annual General Meeting:

 

"I am pleased to report a strong start to 2011 with record sales and profits in both Consumer Care and Industrial Specialities with robust demand continuing across all major geographies.

 

Group sales increased 13.2% to £277.9m (2010: £245.5m) despite adverse currency translation of 2.4%. Overall volumes were slightly down as we continue to reposition our Industrial Specialities operations away from lower price/higher volume products towards more speciality business. Average prices rose during the quarter as we passed on significant raw material cost increases into the market. We have implemented further price increases where necessary in April.

 

Group pre-tax profit from continuing operations increased 40.2% to £60.7m (2010: £43.3m).

 

On a segmental basis, Consumer Care operating profit was up 22.2% to £42.4m (2010: £34.7m) with Personal Care, Health Care and Crop Care all seeing significant sales and profit growth.

 

Industrial Specialities again achieved extremely robust profit growth of 63.7% to £18.5m (2010: £11.3m) despite the volume decline described above and adverse currency movements.

 

Net debt reduced by £5.3m since the year-end to £215.1m despite an unfavourable currency movement of £1.5m.

 

We are pleased with the performance to date and are confident of reporting further progress throughout 2011."

 

 

 

 

For further information, please contact:

 

Mike Humphrey, Group Chief Executive

Tel: 01405 860551

Sean Christie, Group Finance Director

Hazel Stevenson, Financial Dynamics

Tel: 0207 269 7176

 

 

The company will host a conference call for analysts at 8.00am (BST) today:

Dial-In: +44 (0)1452 542 304

Please quote "Croda International"to gain access to the call

 

 

Croda International Plc

Unaudited income statement before tax and exceptional items

31 March 2011

£m

3 months to

3 months to

31 March

31 March

2011

2010

Change

Consumer Care

146.3

128.1

+14.2%

Industrial Specialities

131.6

117.4

+12.1%

Revenues from continuing operations

277.9

245.5

+13.2%

Consumer Care

42.4

34.7

+22.2%

Industrial Specialities

18.5

11.3

+63.7%

Operating profit from continuing operations

60.9

46.0

+32.4%

Net bank and loan interest payable

(2.0)

(2.8)

Net retirement benefit scheme financing

1.8

0.1

Profit before tax from continuing operations

60.7

43.3

+40.2%

Operating margin

21.9%

18.7%

Analysis of turnover uplift for continuing operations

Volume

-0.5%

Currency impact

-2.4%

Price/mix

+16.1%

+13.2%

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIRMATMBJTBJB
Date   Source Headline
29th Apr 201312:20 pmRNSHolding(s) in Company
25th Apr 20133:40 pmRNSResult of AGM
25th Apr 20137:00 amRNSInterim Management Statement
12th Apr 20133:11 pmRNSDirector/PDMR Shareholding
12th Apr 20137:30 amRNSTransaction in Own Shares
28th Mar 201310:14 amRNSDirector/PDMR Shareholding
22nd Mar 20135:30 pmRNSAnnual Financial Report
21st Mar 20137:10 amRNSDirector Declaration
14th Mar 201311:42 amRNSDirector/PDMR Shareholding
12th Mar 20135:35 pmRNSDirector/PDMR Shareholding
26th Feb 20132:34 pmRNSDirector/PDMR Shareholding
26th Feb 20137:00 amRNSPreliminary Results
13th Feb 20139:12 amRNSDirector/PDMR Shareholding
14th Jan 20132:00 pmRNSAcquisition of Innovachem
24th Dec 201211:33 amRNSDirector/PDMR Shareholding
12th Dec 201210:17 amRNSDirector/PDMR Shareholding
29th Nov 20125:18 pmRNSDirector/PDMR Shareholding
23rd Nov 20128:59 amRNSDirector Declaration
22nd Nov 201212:13 pmRNSDirector/PDMR Shareholding
13th Nov 20123:36 pmRNSDirector/PDMR Shareholding
13th Nov 20123:09 pmRNSDirector/PDMR Shareholding
8th Nov 20123:17 pmRNSDirector/PDMR Shareholding
7th Nov 20127:00 amRNSCapital Markets Day
2nd Nov 20122:23 pmRNSDirector/PDMR Shareholding
1st Nov 20127:00 amRNSIMS and announcement of disposal
31st Oct 20129:08 amRNSAppointment of Joint Broker
11th Oct 20125:18 pmRNSDirector/PDMR Shareholding
10th Oct 201212:24 pmRNSDirector/PDMR Shareholding
24th Sep 201210:22 amRNSDirector/PDMR Shareholding
18th Sep 20129:45 amRNSHolding(s) in Company
12th Sep 20128:54 amRNSDirector/PDMR Shareholding
5th Sep 201211:39 amRNSHolding(s) in Company
13th Aug 20124:52 pmRNSDirector/PDMR Shareholding
24th Jul 20127:00 amRNSInterim Results 2012
18th Jul 20124:25 pmRNSHolding(s) in Company
11th Jul 20124:20 pmRNSDirector/PDMR Shareholding
18th Jun 201211:31 amRNSDirector/PDMR Shareholding
13th Jun 20128:44 amRNSDirector/PDMR Shareholding - Replacement
12th Jun 20125:02 pmRNSDirector/PDMR Shareholding
11th May 20124:26 pmRNSDirector/PDMR Shareholding
1st May 20121:45 pmRNSDirector/PDMR Shareholding
26th Apr 20123:17 pmRNSResult of AGM
26th Apr 20127:00 amRNSFirst quarter trading statement
11th Apr 20124:28 pmRNSDirector/PDMR Shareholding
5th Apr 20122:15 pmRNSAnnual Information Update
29th Mar 20122:33 pmRNSDirector/PDMR Shareholding
27th Mar 20122:43 pmRNSDirector/PDMR Shareholding
26th Mar 201211:09 amRNSAnnual Financial Report
22nd Mar 20124:56 pmRNSDirector/PDMR Shareholding
16th Mar 20123:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.